Navigation Links
Reducing the side effects of treatment for prostate cancer
Date:8/27/2012

New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen used to treat breast cancer, is also able to suppress gynecomastia and breast pain in men.

Prostate cancer is one of the most common cancers in men and early treatment is usually very successful. Androgen-suppression therapy is often used to slow down progression of advanced disease. However, unwanted side effects of anti-androgen treatment, such as breast enlargement, can stop men from seeking treatment for their cancer.

Testosterone can drive the growth of prostate cancer and anti-androgens are used to inhibit prostate cancer growth by preventing testosterone from binding to androgen receptors. But receptors in cells within the testes are also blocked and start to make more testosterone to compensate. Some of this extra testosterone is converted into estrogen which is responsible for development of breast tissue and other breast events. Anti-estrogens work by jamming the estrogen receptor, while aromatase inhibitors prevent the conversion of testosterone into estrogen.

A collaboration between the German Cochrane Center and University Clinic Erlangen combined data from four independent clinical trials each looking at the management of breast events (during treatment for prostate cancer) with tamoxifen.

A meta-analysis of all four trials showed that tamoxifen reduced the risk of both gynecomastia and breast pain at 3, 6, 9, and 12 months of treatment compared to men who received no treatment. Overall, treatment with tamoxifen was more successful in reducing breast symptoms than treatment with an aromatase inhibitor (anastrazole) or radiotherapy.

Although there is no long term data available, few of the men treated with tamoxifen, either as preventative or therapeutic treatment, stopped taking their medication during their year of treatment. There were also no significant adverse effects.

Dr Frank Kunath, who led this study explained, "Not all men will suffer gynecomastia during anti-androgen therapy. However, if men know that there is a successful option for reducing the breast symptoms associated with treatment for prostate cancer they may be more likely to see their doctor when symptoms of cancer first appear, and consequently reduce the number of unnecessary deaths."


'/>"/>
Contact: Hilary Glover
hilary.glover@biomedcentral.com
44-020-319-22370
BioMed Central
Source:Eurekalert

Related medicine news :

1. Researchers determine vitamin D blood level for reducing major medical risks in older adults
2. Reducing post-traumatic stress after ICU
3. Reducing off-label use of antipsychotic medications may save money
4. No Progress in Reducing U.S. Motorcycle Deaths: Report
5. Kitchen exhaust fans vary in effectiveness in reducing indoor air pollution
6. HPV Vaccine Reducing Infections, Even Among Unvaccinated: Study
7. A nursing program shows promise for reducing deaths from chronic illnesses
8. Reducing Ozone Limits Would Save Lives, Report States
9. Timing of antibiotics important in reducing infections after C-section
10. Young girls more likely to report side effects after HPV vaccine
11. Preteens More Likely to Report HPV Vaccine Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , ... March 22, 2017 , ... ... the publication of the first issue of its companion print magazine. The new ... about cosmetic surgery thanks to information provided by board-certified doctors from across the ...
(Date:3/22/2017)... ... March 22, 2017 , ... Old School Labs™, makers ... Ashley Theophane as a new Brand Ambassador. Theophane, who trained with Floyd Mayweather, made ... in 2011. He has racked up an impressive number of wins in contests in ...
(Date:3/22/2017)... Ala. (PRWEB) , ... March 22, 2017 , ... ... experience solution provider, today announced that its digital marketing solutions have enabled Children’s ... marketing investment in 24 months. , Recognizing the value of a digital ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... into a research collaboration to translate advances in basic neuroscience at the BMRI ... and beyond. The collaboration seeks to improve movement, vision, and cognition impaired by stroke, ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a Long Island firm ... region, is embarking on a combined charity effort with the Great Neck Breast Cancer ... 25 years, the Great Neck Breast Cancer Coalition has worked to support breast cancer ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... MARLBOROUGH, Mass. , March 22, 2017 ... that it has completed the acquisition of Cynosure, Inc., ... $66 per share in cash. "We are ... forward to working with Michael Davin and ... in the large, rapidly growing medical aesthetics market," said ...
(Date:3/22/2017)... 22, 2017 FinancialBuzz.com News Commentary ... cannabis industry is strongly contributing to job creation. A ... and reporting for the cannabis industry, projects that by ... a quarter million jobs for American workers. The legal ... 2016, and is projected to grow at a compound ...
(Date:3/22/2017)... Minn. , March 22, 2017   Upsher-Smith Laboratories, ... Hydrochloride Capsules* USP, 25 mg, 50 mg and 75 mg, ... hydrochloride) Capsules USP. The clomipramine hydrochloride capsules ... 12 months ending December 2016, according to IMS Health. ... "Upsher-Smith has ...
Breaking Medicine Technology: